AstraZeneca announced on Tuesday it has suspended global trials of its coronavirus vaccine, in a fresh setback for the global race to find a vaccine. The decision to pause the trials, including large late-stage trials, was taken after a study participant developed an unexplained illness. (www.euractiv.com)
